Literature DB >> 15463808

Hypertonic saline and recombinant human DNase: a randomised cross-over pilot study in patients with cystic fibrosis.

Manfred Ballmann1, Horst von der Hardt.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 15463808     DOI: 10.1016/s1569-1993(01)00009-1

Source DB:  PubMed          Journal:  J Cyst Fibros        ISSN: 1569-1993            Impact factor:   5.482


× No keyword cloud information.
  20 in total

1.  Extracellular DNA in single- and multiple-species unsaturated biofilms.

Authors:  R E Steinberger; P A Holden
Journal:  Appl Environ Microbiol       Date:  2005-09       Impact factor: 4.792

2.  Hypertonic saline inhalation in cystic fibrosis--salt in the wound, or sweet success?

Authors:  Beth Enderby; Iolo Doull
Journal:  Arch Dis Child       Date:  2007-03       Impact factor: 3.791

Review 3.  Timing of hypertonic saline inhalation for cystic fibrosis.

Authors:  Mark Elkins; Ruth Dentice
Journal:  Cochrane Database Syst Rev       Date:  2016-12-22

4.  Inhaled hypertonic saline in infants and toddlers with cystic fibrosis: short-term tolerability, adherence, and safety.

Authors:  Margaret Rosenfeld; Stephanie Davis; Lyndia Brumback; Stephen Daniel; Ron Rowbotham; Robin Johnson; Sharon McNamara; Renee Jensen; Carol Barlow; Felix Ratjen
Journal:  Pediatr Pulmonol       Date:  2011-03-01

Review 5.  Stenotrophomonas maltophilia: an emerging global opportunistic pathogen.

Authors:  Joanna S Brooke
Journal:  Clin Microbiol Rev       Date:  2012-01       Impact factor: 26.132

Review 6.  Timing of dornase alfa inhalation for cystic fibrosis.

Authors:  Ruth Dentice; Mark Elkins
Journal:  Cochrane Database Syst Rev       Date:  2016-07-26

Review 7.  Inhaled hypertonic saline for cystic fibrosis: Reviewing the potential evidence for modulation of neutrophil signalling and function.

Authors:  Emer P Reeves; Cormac McCarthy; Oliver J McElvaney; Maya Sakthi N Vijayan; Michelle M White; Danielle M Dunlea; Kerstin Pohl; Noreen Lacey; Noel G McElvaney
Journal:  World J Crit Care Med       Date:  2015-08-04

8.  Inhibitory effects of hypertonic saline on P. aeruginosa motility.

Authors:  Viktória Havasi; Casey O Hurst; Travis C Briles; Fan Yang; David G Bains; Daniel J Hassett; Eric Sorscher
Journal:  J Cyst Fibros       Date:  2008-01-31       Impact factor: 5.482

Review 9.  Hypertonic saline in treatment of pulmonary disease in cystic fibrosis.

Authors:  Emer P Reeves; Kevin Molloy; Kerstin Pohl; Noel G McElvaney
Journal:  ScientificWorldJournal       Date:  2012-05-03

10.  Timing of dornase alfa inhalation for cystic fibrosis.

Authors:  Ruth Dentice; Mark Elkins
Journal:  Cochrane Database Syst Rev       Date:  2021-03-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.